Mapping microscopic pathology of Alzheimer's disease in 3D

March 15, 2024 08:30 AM AEDT | By EIN Presswire
 Mapping microscopic pathology of Alzheimer's disease in 3D
Image source: EIN Presswire

MADRID, MADRID, SPAIN, March 14, 2024 /EINPresswire.com/ -- Scientists are determined to tackle the complexities of Alzheimer’s disease, a condition known for its devastating impact on memory and cognitive function. A new study presents an innovative method to examine Alzheimer's pathology within the human brain, particularly in the hippocampus, a structure crucial for memory function. The main question the research sought to answer was how the distribution of Alzheimer’s pathology varies along the length of the hippocampus.

This study, product of a collaboration between the Laboratory for Clinical Neuroscience, Universidad Politécnica de Madrid (Spain), Fundación CIEN (Spain) and the Massachusetts General Hospital - Harvard Medical School (USA), employed a pioneering technique which allows 3D mapping of human brain histology. Using microscopes to observe histology sections from human post-mortem brain samples is instrumental in clinical practice and neuroscience, particularly in diagnosing Alzheimer’s and other dementias. However, traditional histology methods are limited to 2D observations and are subject to considerable variability due to manual brain tissue sampling. Therefore, histology sections from different subjects often come from different positions within the brain, challenging comparisons across subjects and the generalization of findings.

To overcome these challenges, other researchers had aligned consecutive histology sections to create a comprehensive 3D representation of brain structures. Unfortunately, processing of a whole brain region, let alone of the entire brain, is not a feasible routine procedure due to time and resource constraints. The technique introduced in this new study, led by Bryan Strange and Juan Eugenio Iglesias, enables for the first time 3D histology analyses without whole-sample processing nor any additional structure references. This technique requires only a photograph of brain slices obtained during dissection to reconstruct the 3D structure of the whole brain. Machine learning is then used to generate an MRI-like image from this 3D reconstruction, providing a reference to align histology sections to their precise anatomical positions. The researchers named this technique Path2MR, which they used to study Alzheimer’s pathology along the hippocampus and gain valuable insights into its spatial distribution.

The researchers examined the distribution of deposits of tau and amyloid, two pathological proteins which are the hallmarks of Alzheimer's disease. For that purpose, they used valuable samples from Alzheimer’s patients collected with support of the Reina Sofia Foundation, in Madrid. These 3D analyses unveiled distinct distributions for these two pathologies along the hippocampus: tau pathology peaked at the anterior (front) end, while amyloid spread across the hippocampus in an “inverted-U” fashion. Amyloid pathology also displayed more complex gradients in other directions, with variable deposition patterns across different subfields of the hippocampus.

The authors concluded that Path2MR provides valuable insights into the distribution of Alzheimer’s pathology, opening new possibilities for understanding the intricate ways in which this disease affects the human brain. “Path2MR is a versatile tool which can map to 3D any observation made under the microscope at hospitals or research institutions. This means we can localize cellular or pathological alterations with much higher precision”. says Diana Ortega-Cruz, the first author of this study. In the field of Alzheimer’s, such 3D analyses can inform about the interaction between pathologies and their downstream effects, informing future treatment and diagnostic options.

Link to the complete article: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13695

Bryan Strange
Universidad Politécnica de Madrid
[email protected]
Visit us on social media:
Twitter
Other


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.